Log in to save to my catalogue

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3aaa0cd884604853a09c4ce5fdef3fa5

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

About this item

Full title

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

Publisher

England: BioMed Central Ltd

Journal title

Alzheimer's research & therapy, 2018-09, Vol.10 (1), p.99-99, Article 99

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Following publication of the original article [1], the author reported errors in the formatting of the table. The details of the errors are as follows.

Alternative Titles

Full title

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3aaa0cd884604853a09c4ce5fdef3fa5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3aaa0cd884604853a09c4ce5fdef3fa5

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-018-0409-4

How to access this item